We are live on ! Find out more
LAB icon

Standard BioTools

106 hedge funds and large institutions have $306M invested in Standard BioTools in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more call options, than puts

Call options by funds: $20M | Put options by funds: $9.99M

22% more capital invested

Capital invested by funds: $252M → $306M (+$54.2M)

3% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 30

3% less funds holding

Funds holding: 109106 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

Holders
106
Holders Change
-3
Holders Change %
-2.75%
% of All Funds
2.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
29
Reduced
30
Closed
22
Calls
$20M
Puts
$9.99M
Net Calls
+$9.99M
Net Calls Change
+$4.85M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$46.1M
O
2
OrbiMed
New York
$26.5M
WA
3
Wasatch Advisors
Utah
$26.1M -$220K -22,423 -0.9%
Franklin Resources
4
Franklin Resources
California
$22.5M -$7.43M -756,653 -27%
CWAM
5
Columbia Wanger Asset Management
Illinois
$19.3M +$17.6M +1,788,773 New
SCM
6
Scopia Capital Management
New York
$16.3M +$1.97M +200,330 +15%
Vanguard Group
7
Vanguard Group
Pennsylvania
$10.6M -$132K -13,454 -1%
BFA
8
BlackRock Fund Advisors
California
$9.55M +$430K +43,833 +5%
BIT
9
BlackRock Institutional Trust
California
$8.7M +$705K +71,810 +10%
Capital World Investors
10
Capital World Investors
California
$8.65M
Jennison Associates
11
Jennison Associates
New York
$8.29M -$3.15M -320,506 -29%
Wellington Management Group
12
Wellington Management Group
Massachusetts
$8.08M +$1.12M +113,932 +18%
Goldman Sachs
13
Goldman Sachs
New York
$6.77M +$1.57M +160,175 +34%
Schroder Investment Management Group
14
Schroder Investment Management Group
United Kingdom
$6.62M -$1.16M -117,900 -16%
Millennium Management
15
Millennium Management
New York
$6.61M -$211K -21,527 -3%
Neuberger Berman Group
16
Neuberger Berman Group
New York
$6.19M +$1.55M +157,760 +38%
State Street
17
State Street
Massachusetts
$4.82M +$58.8K +5,987 +1%
ECM
18
Endurant Capital Management
California
$4.36M -$928K -94,478 -19%
Lazard Asset Management
19
Lazard Asset Management
New York
$4.22M -$1.47M -149,904 -28%
Northern Trust
20
Northern Trust
Illinois
$4.03M +$186K +18,983 +5%
Citadel Advisors
21
Citadel Advisors
Florida
$2.93M -$3.5M -355,930 -57%
HCMT
22
Highland Capital Management (Texas)
Texas
$2.91M -$1.37M -139,294 -34%
Deutsche Bank
23
Deutsche Bank
Germany
$2.86M -$847K -86,282 -25%
SM
24
Sabby Management
Florida
$2.86M -$3.58M -364,064 -58%
BIM
25
Bogle Investment Management
Massachusetts
$2.86M +$2.03M +207,213 +364%

LAB Hedge Fund Activity: Q4 2015 in Review

106 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2015, worth a combined $306M — up 22% from $252M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LAB and 19 opened new positions — a net loss of 3 holders — while 30 trimmed existing stakes and 29 added.

The largest buyer was Columbia Wanger Asset Management, opening a new position worth an estimated $17.6M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $16.2M sold.

  • 106 institutional investors held Standard BioTools (LAB) as of Q4 2015, down from 109 in Q3 2015.
  • Funds reported $306M of Standard BioTools stock for Q4 2015, up 22% quarter-over-quarter.
  • 19 funds opened new Standard BioTools positions in Q4 2015 and 22 closed out, a net change of -3 holders.
  • The largest Standard BioTools buyer in Q4 2015 was Columbia Wanger Asset Management, an estimated $17.6M added.
  • The largest Standard BioTools seller in Q4 2015 was JP Morgan Chase, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2015.